Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bemesetron

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bemesetron in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(bemesetron)		Trials
(bemesetron)		Recent Studies (post-2010) (bemesetron)
9,156187552254325

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)bemesetron (IC50)
5-hydroxytryptamine receptor 3EHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3BHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.097
5-hydroxytryptamine receptor 3AHomo sapiens (human)0.0928
5-hydroxytryptamine receptor 3DHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3CHomo sapiens (human)0.0093
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.097

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bemesetron

ArticleYear
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship

2013